Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20161
20171
20181
20192
20201
20212
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Seagen Inc.2
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Blueprint Medicines Corporation1
Exelixis1
GlaxoSmithKline1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms16
Carcinoma, Non-Small-Cell Lung9
Endometrial Neoplasms8
Colorectal Neoplasms7
Triple Negative Breast Neoplasms6
Breast Neoplasms5
Esophageal Neoplasms5
Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Stomach Neoplasms5

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.